Previous research has shown that low IGF-1R expression in the tumor is predictive for pathological complete response (pCR) in ER-positive tumors [10] and that upregulation of IGF-1R during chemotherapy predicts a poor outcome in a relative small, heterogeneous group of BC patients [18]. Here, IGF1R is linked to neoplasm.